Detailed View
IBRX - ImmunityBio, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
7,342,625,792
Adj EBIT (TTM)
-256,027,000
Enterprise Value
6,925,687,792
Last Price
7.11
Earnings Yield
-3.70%
Return on Capital
-61.96%
Capital
413,200,000
1Y Price Chart
Last Price: $7.11
1Y Change: 185.54%
As of 2026-05-01 | 1Y Change: 185.54%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 38,285,000 | -64,683,000 |
| 2025-09-30 | 10-Q | 2025 | 32,061,000 | -55,630,000 |
| 2025-06-30 | 10-Q | 2025 | 26,425,000 | -71,285,000 |
| 2025-03-31 | 10-Q | 2025 | 16,517,000 | -64,429,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 7,552,000 | -69,400,000 |
| 2024-09-30 | 10-Q | 2024 | 6,106,000 | -80,253,000 |
| 2024-06-30 | 10-Q | 2024 | 1,047,000 | -99,333,000 |
| 2024-03-31 | 10-Q | 2024 | 40,000 | -95,196,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.